drugset / Trial / NCT00327704

Early Albumin Resuscitation During Septic Shock

NCT00327704

Phase 4 Completed 794 enrolled LFB
RandomizedParallel-groupOpen-labelTreatment

Summary

Objective: To determine whether the early administration of albumin as an expander and antioxidant would improve survival on the 28th day for septic shock patients. Design: Prospective, multicenter, randomized, controlled versus saline, stratified on nosocomial infection and center. Setting: 27 Intensive Care Units (ICU) in France Coordinator: Pr J.P. Mira and Dr J. Charpentier - Cochin Hospital- Paris Patients: 800 patients could be included during the first 6 hours of their septic shock.

Timeline

Start
2006-07
Primary completion
2010-06
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albumin Protein / enzyme biologic 100 ml